Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Fitzgerald

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
Biomolecules|September 22, 2020
Targeting Receptors on Cancer Cells with Protein ToxinsAntonella Antignani, Eric Chun Hei Ho, Maria Teresa Bilotta, et al.
Blood|November 8, 2008
A protease-resistant immunotoxin against CD22 with greatly increased activity against CLL and diminished animal toxicityJohn E Weldon, Laiman Xiang, Oleg Chertov, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 18, 2012
Immunotoxin resistance via reversible methylation of the DPH4 promoter is a unique survival strategyHui Wei, Laiman Xiang, Alan S Wayne, et al.
Cancer Research|January 1, 2016
Anticancer Effects of Mesothelin-Targeted Immunotoxin Therapy Are Regulated by Tyrosine Kinase DDR1Fatima Ali-Rahmani, David J FitzGerald, Scott Martin, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 26, 2015
Whole-genome RNAi screen highlights components of the endoplasmic reticulum/Golgi as a source of resistance to immunotoxin-mediated cytotoxicityMatteo Pasetto, Antonella Antignani, Pinar Ormanoglu, et al.
The Journal of Biological Chemistry|February 14, 2009
Proteolytic cleavage of a C-terminal prosequence, leading to autoprocessing at the N Terminus, activates leucine aminopeptidase from Pseudomonas aeruginosaRobert Sarnovsky, Jennifer Rea, Matt Makowski, et al.
Molecular Cancer Therapeutics|July 1, 2010
ABT-737 overcomes resistance to immunotoxin-mediated apoptosis and enhances the delivery of pseudomonas exotoxin-based proteins to the cell cytosolRoberta Traini, Gal Ben-Josef, Diana V Pastrana, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 4, 2014
Tofacitinib suppresses antibody responses to protein therapeutics in murine hostsMasanori Onda, Kamran Ghoreschi, Scott Steward-Tharp, et al.
Cancer Immunology, Immunotherapy : CII|January 22, 2010
Initial characterization of an immunotoxin constructed from domains II and III of cholera exotoxinRobert Sarnovsky, Tara Tendler, Matheusz Makowski, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 24, 2004
Identification of tandem duplicate regulatory small RNAs in Pseudomonas aeruginosa involved in iron homeostasisPaula J Wilderman, Nathaniel A Sowa, David J FitzGerald, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Biomolecules|September 22, 2020
Targeting Receptors on Cancer Cells with Protein ToxinsAntonella Antignani, Eric Chun Hei Ho, Maria Teresa Bilotta, et al.
Blood|November 8, 2008
A protease-resistant immunotoxin against CD22 with greatly increased activity against CLL and diminished animal toxicityJohn E Weldon, Laiman Xiang, Oleg Chertov, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 18, 2012
Immunotoxin resistance via reversible methylation of the DPH4 promoter is a unique survival strategyHui Wei, Laiman Xiang, Alan S Wayne, et al.
Cancer Research|January 1, 2016
Anticancer Effects of Mesothelin-Targeted Immunotoxin Therapy Are Regulated by Tyrosine Kinase DDR1Fatima Ali-Rahmani, David J FitzGerald, Scott Martin, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 26, 2015
Whole-genome RNAi screen highlights components of the endoplasmic reticulum/Golgi as a source of resistance to immunotoxin-mediated cytotoxicityMatteo Pasetto, Antonella Antignani, Pinar Ormanoglu, et al.
The Journal of Biological Chemistry|February 14, 2009
Proteolytic cleavage of a C-terminal prosequence, leading to autoprocessing at the N Terminus, activates leucine aminopeptidase from Pseudomonas aeruginosaRobert Sarnovsky, Jennifer Rea, Matt Makowski, et al.
Molecular Cancer Therapeutics|July 1, 2010
ABT-737 overcomes resistance to immunotoxin-mediated apoptosis and enhances the delivery of pseudomonas exotoxin-based proteins to the cell cytosolRoberta Traini, Gal Ben-Josef, Diana V Pastrana, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 4, 2014
Tofacitinib suppresses antibody responses to protein therapeutics in murine hostsMasanori Onda, Kamran Ghoreschi, Scott Steward-Tharp, et al.
Cancer Immunology, Immunotherapy : CII|January 22, 2010
Initial characterization of an immunotoxin constructed from domains II and III of cholera exotoxinRobert Sarnovsky, Tara Tendler, Matheusz Makowski, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 24, 2004
Identification of tandem duplicate regulatory small RNAs in Pseudomonas aeruginosa involved in iron homeostasisPaula J Wilderman, Nathaniel A Sowa, David J FitzGerald, et al.
Pageof 5